vs
Side-by-side financial comparison of Dime Community Bancshares, Inc. (DCOM) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Dime Community Bancshares, Inc. is the larger business by last-quarter revenue ($123.8M vs $70.6M, roughly 1.8× Viridian Therapeutics, Inc.\DE). On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 3040.1%).
The Dime Community Bank, originally known as the Dime Savings Bank of Williamsburgh, is a local, FDIC-insured bank headquartered in Hauppauge, New York. Founded in 1864, the bank was originally based in the Williamsburg neighborhood of Brooklyn, New York, and continues to operate with a strong market presence in this area. In 2017, Dime moved its headquarters to Brooklyn Heights. On Monday, February 1, 2021, Bridge Bancorp Inc. and Dime Community Bancshares successfully closed on a merger of ...
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
DCOM vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $70.6M |
| Net Profit | — | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 38.6% | -56.7% |
| Net Margin | — | -49.0% |
| Revenue YoY | 3040.1% | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $0.68 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | — | ||
| Q3 25 | $115.6M | $70.6M | ||
| Q2 25 | $109.7M | — | ||
| Q1 25 | $103.8M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $87.6M | — | ||
| Q2 24 | $87.3M | — | ||
| Q1 24 | $82.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | $27.7M | $-34.6M | ||
| Q2 25 | $29.7M | — | ||
| Q1 25 | $21.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.3M | — | ||
| Q2 24 | $18.5M | — | ||
| Q1 24 | $17.7M | — |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 34.7% | -56.7% | ||
| Q2 25 | 36.6% | — | ||
| Q1 25 | 27.6% | — | ||
| Q4 24 | -433.6% | — | ||
| Q3 24 | 20.8% | — | ||
| Q2 24 | 29.8% | — | ||
| Q1 24 | 29.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 23.9% | -49.0% | ||
| Q2 25 | 27.1% | — | ||
| Q1 25 | 20.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 21.6% | — |
| Q4 25 | $0.68 | — | ||
| Q3 25 | $0.59 | — | ||
| Q2 25 | $0.64 | — | ||
| Q1 25 | $0.45 | — | ||
| Q4 24 | $-0.58 | — | ||
| Q3 24 | $0.29 | — | ||
| Q2 24 | $0.43 | — | ||
| Q1 24 | $0.41 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $503.0M |
| Total Assets | $15.3B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $503.0M | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $15.3B | — | ||
| Q3 25 | $14.5B | $577.1M | ||
| Q2 25 | $14.2B | — | ||
| Q1 25 | $14.1B | — | ||
| Q4 24 | $14.4B | — | ||
| Q3 24 | $13.7B | — | ||
| Q2 24 | $13.5B | — | ||
| Q1 24 | $13.5B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $186.6M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $186.6M | — | ||
| Q3 25 | $52.1M | $-84.6M | ||
| Q2 25 | $23.1M | — | ||
| Q1 25 | $65.4M | — | ||
| Q4 24 | $99.1M | — | ||
| Q3 24 | $-33.3M | — | ||
| Q2 24 | $12.6M | — | ||
| Q1 24 | $30.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | $51.2M | $-84.7M | ||
| Q2 25 | $20.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-34.1M | — | ||
| Q2 24 | $9.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 44.3% | -120.1% | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.9% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.7% | 0.2% | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 3.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.50× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 1.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
